Skip to main content
Lepu Medical Technology (Beijing) Co.,Ltd. logo

Lepu Medical Technology (Beijing) Co.,Ltd. — Investor Relations & Filings

Ticker · 300003 ISIN · CNE100000H44 LEI · 3003007FXUYE3WNDDO39 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,405 across all filing types
Latest filing 2026-05-13 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 300003

About Lepu Medical Technology (Beijing) Co.,Ltd.

https://www.lepumedical.com

Lepu Medical Technology (Beijing) Co.,Ltd. specializes in the development, manufacture, and distribution of medical devices and equipment, primarily focused on cardiovascular disease management. The company provides a comprehensive range of products spanning the entire patient care cycle, including prevention, screening, diagnosis, treatment, and rehabilitation. Its core portfolio features interventional cardiology solutions such as coronary stents, bioresorbable scaffolds, and PTCA balloon catheters. Additionally, the company offers structural heart disease devices, cardiac rhythm management systems, and anesthesia products. Lepu Medical also maintains a significant presence in the in vitro diagnostics (IVD) sector and produces advanced medical electronic equipment, including ECG machines and patient monitors. By leveraging integrated R&D and manufacturing capabilities, the company serves healthcare providers worldwide with innovative medical solutions.

Recent filings

Filing Released Lang Actions
北京市中伦律师事务所关于公司2025年度股东会的法律意见书
Regulatory Filings Classification · 90% confidence The document is a standalone “法律意见书” (legal opinion letter) prepared by Zhong Lun law firm regarding the 2025 annual shareholders’ meeting procedures, attendance and voting. It does not present financial statements, earnings data, or investor slide materials (so it is not an Annual Report, Interim Report, ER, IP, etc.). It is also not a proxy solicitation package or notice requesting votes in the usual PSI format. It is essentially a compliance/legal opinion filed alongside the AGM materials. This type of legal compliance opinion does not neatly fit any more specific code, so it falls under the fallback regulatory filing category (RNS).
2026-05-13 Chinese
关于选举产生第七届董事会职工代表董事的公告
Board/Management Information Classification · 90% confidence The document is an official announcement by LePu (Beijing) Medical Devices Co., Ltd. regarding the election of an employee‐representative director to the 7th Board of Directors. It describes the process, the elected individual, and her qualifications, which constitutes a change in the company’s board composition. This corresponds to a Board/Management Information filing.
2026-05-13 Chinese
2025年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 98% confidence The document is titled “2025年年度股东会决议公告” and details the convening of the Annual General Meeting, lists each agenda item, and provides vote counts (agree, disagree, abstain) for each resolution. This is a formal announcement of AGM voting results. It is not the full report or presentation, but the declaration of voting outcomes, matching the DVA category.
2026-05-13 Chinese
第七届董事会第一次会议决议公告
Board/Management Information Classification · 91% confidence The document is an announcement of the resolutions of the company’s seventh Board of Directors first meeting, detailing the election of the Board chairman and vice chairman, appointment of Board committee members, and hiring of senior management. This clearly falls under announcements of changes in board composition and senior management, matching the “Board/Management Information” category.
2026-05-13 Chinese
关于董事会完成换届选举及聘任高级管理人员的公告
Board/Management Information Classification · 95% confidence The document is a formal announcement by 乐普（北京）医疗器械股份有限公司 about the completion of the board re-election and the appointment of senior management personnel, listing the new board members, committee compositions, and names of newly appointed executives. This clearly falls under announcements of changes in the company's board of directors and senior management (Board/Management Information).
2026-05-13 Chinese
公司章程（2026年4月）
Governance Information Classification · 95% confidence The document is clearly the full Articles of Association (公司章程) of 乐普（北京）医疗器械股份有限公司, detailing the company’s internal rules, organizational structure, shareholder rights, board and committee provisions, and governance procedures. It is not an announcement or summary but the primary governance charter, fitting the Governance Information definition (CGR).
2026-04-22 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.